Innate Pharma S.A. (FR:IPH) has released an update.
Innate Pharma SA, a global biotech leader in cancer immunotherapies, has announced its participation in the 2nd Annual H.C. Wainwright Cell Therapy Virtual Conference. The company is known for its pioneering work in therapeutic antibodies and its proprietary ANKET platform, with key programs in advanced lymphomas and a partnership with AstraZeneca in non-small cell lung cancer. Headquartered in Marseille with a US office, Innate Pharma is poised to share its latest developments with investors and stakeholders.
For further insights into FR:IPH stock, check out TipRanks’ Stock Analysis page.